Pharma

FDA
Manufacturing

Hansoh, Samsung Bio written up after FDA inspections

Hansoh was mainly chided for insufficient sterilization, whereas the Samsung Bio Form 483, issued last year, featured data falsification accusations.
Donavyn Coffey Nov 2, 2026 2:56pm
photo of a green light on a stoplight

Inovio wins FDA nod for DNA-based immunotherapy in rare disease

Nov 2, 2026 10:53am
Resource Icon
The direct-to-patient DTP market is full of providers making bold claims But claims are not outcomes To unlock the true p

DTP – Delivering Proof Over Promise

Brought to you by Gifthealth
bid

Karyopharm files Chapter 11 ahead of Ayrmid merger

Nov 2, 2026 10:46am
Podcast
How AI turns field conversations into actionable insights

How AI turns field conversations into actionable insights

Brought to you by Inizio
Graphic image of a compass above an unfolded map Orange background color

Compass points to unmet need as psychedelic nears market

Nov 2, 2026 10:33am